Cowden syndrome pathophysiology: Difference between revisions
| Line 47: | Line 47: | ||
[[Cowden syndrome]] is transmitted in [[autosomal dominant]] pattern.<ref name="Eng2000">{{cite journal|last1=Eng|first1=C.|title=Will the real Cowden syndrome please stand up: revised diagnostic criteria|journal=Journal of Medical Genetics|volume=37|issue=11|year=2000|pages=828–830|issn=14686244|doi=10.1136/jmg.37.11.828}}</ref> | [[Cowden syndrome]] is transmitted in [[autosomal dominant]] pattern.<ref name="Eng2000">{{cite journal|last1=Eng|first1=C.|title=Will the real Cowden syndrome please stand up: revised diagnostic criteria|journal=Journal of Medical Genetics|volume=37|issue=11|year=2000|pages=828–830|issn=14686244|doi=10.1136/jmg.37.11.828}}</ref> | ||
Genes involved in the pathogenesis of [[cowden syndrome]]<nowiki/>include: | Genes involved in the pathogenesis of [[cowden syndrome]]<nowiki/>include:<ref name="PilarskiBurt2013">{{cite journal|last1=Pilarski|first1=R.|last2=Burt|first2=R.|last3=Kohlman|first3=W.|last4=Pho|first4=L.|last5=Shannon|first5=K. M.|last6=Swisher|first6=E.|title=Cowden Syndrome and the PTEN Hamartoma Tumor Syndrome: Systematic Review and Revised Diagnostic Criteria|journal=JNCI Journal of the National Cancer Institute|volume=105|issue=21|year=2013|pages=1607–1616|issn=0027-8874|doi=10.1093/jnci/djt277}}</ref> | ||
*[[Phosphatase]] and tensin homolog (''[[PTEN (gene)|PTEN]]'') gene | *[[Phosphatase]] and tensin homolog (''[[PTEN (gene)|PTEN]]'') gene | ||
*[Gene2] | *[Gene2] | ||
Revision as of 20:13, 18 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
The exact pathogenesis of [disease name] is not fully understood.
OR
It is thought that cowden syndrome is the result caused by phosphatase and tensin homolog (PTEN) gene mutations. Cowden syndrome follows autosomal dominant pattern of inheritance.
OR
[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
OR
Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
OR
[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
OR
The progression to [disease name] usually involves the [molecular pathway].
OR
The pathophysiology of [disease/malignancy] depends on the histological subtype.
Pathophysiology
Physiology
The normal physiology of [name of process] can be understood as follows:
Pathogenesis
- The exact pathogenesis of [disease name] is not completely understood.
OR
- It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
- [Pathogen name] is usually transmitted via the [transmission route] route to the human host.
- Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
- [Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
- The progression to [disease name] usually involves the [molecular pathway].
- The pathophysiology of [disease/malignancy] depends on the histological subtype.
Genetics
Cowden syndrome is transmitted in autosomal dominant pattern.[1]
Genes involved in the pathogenesis of cowden syndromeinclude:[2]
- Phosphatase and tensin homolog (PTEN) gene
- [Gene2]
- [Gene3]
OR
The development of [disease name] is the result of multiple genetic mutations such as:
- [Mutation 1]
- [Mutation 2]
- [Mutation 3]
Associated Conditions
Conditions associated with [disease name] include:
- [Condition 1]
- [Condition 2]
- [Condition 3]
Gross Pathology
On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
Microscopic Pathology
On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
References
- ↑ Eng, C. (2000). "Will the real Cowden syndrome please stand up: revised diagnostic criteria". Journal of Medical Genetics. 37 (11): 828–830. doi:10.1136/jmg.37.11.828. ISSN 1468-6244.
- ↑ Pilarski, R.; Burt, R.; Kohlman, W.; Pho, L.; Shannon, K. M.; Swisher, E. (2013). "Cowden Syndrome and the PTEN Hamartoma Tumor Syndrome: Systematic Review and Revised Diagnostic Criteria". JNCI Journal of the National Cancer Institute. 105 (21): 1607–1616. doi:10.1093/jnci/djt277. ISSN 0027-8874.